Key statistics
On Tuesday, Elanco Animal Health Inc (ELAN:NYQ) closed at 13.39, 17.46% above the 52 week low of 11.40 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.49 |
---|---|
High | 13.65 |
Low | 13.26 |
Bid | 12.90 |
Offer | 13.67 |
Previous close | 13.36 |
Average volume | 3.95m |
---|---|
Shares outstanding | 494.35m |
Free float | 491.10m |
P/E (TTM) | 32.69 |
Market cap | 6.60bn USD |
EPS (TTM) | 0.4087 USD |
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
- Elanco to Participate in the Upcoming Investor Conferences
- Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain
- Elanco Strengthens Board of Directors with Addition of Stacey Ma
- Elanco Animal Health Reports Third Quarter 2024 Results
- Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement
- Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose
- Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
- Elanco Provides Update on Contract Manufacturing Partner
- Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼